In Vitro Depletion of Tissue-Derived Dendritic Cells by CMRF-44 Antibody and Alemtuzumab: Implications for the Control of Graft-Versus-Host Disease-Reference-Cited by-同舟云学术

In Vitro Depletion of Tissue-Derived Dendritic Cells by CMRF-44 Antibody and Alemtuzumab: Implications for the Control of Graft-Versus-Host Disease

Published:2005-03-27 Issue:6 Volume:79 Page:722-725
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Collin Matthew P.,Munster David,Clark Georgina,Wang Xiao-Nong,Dickinson Anne M.,Hart Derek N.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference20 articles.

1. Antigen presentation in graft-vs-host disease.;Shlomchik;Exp Hematol,2003

2. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease.;Merad;Nat Med,2004

3. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant.;Vogelsang;Annu Rev Med,2003

4. Reconstitution of thymic function after stem cell transplantation in humans.;Hakim;Curr Opin Hematol,2002

5. Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells.;Hock;Immunology,1994

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic Cells in Hematopoietic Cell Transplantation;Advances and Controversies in Hematopoietic Transplantation and Cell Therapy;2018-11-28

2. The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-Versus-Host Disease;Biomedicines;2017-11-29

3. Dendritic Cells in Hematopoietic Cell Transplantation;Thomas’ Hematopoietic Cell Transplantation;2016-01-01

4. Reconsideration of Age as a Contraindication for Curative Therapy of Sickle Cell Disease;JAMA;2014-07-02

5. Definition of the Variables Affecting Efficacy of Immunodepletion Ex Vivo of Peripheral Blood Progenitor Cell Grafts by Alemtuzumab (Campath in the Bag);Biology of Blood and Marrow Transplantation;2013-12